Jacks Lee - Jun 15, 2023 Form 4 Insider Report for G1 Therapeutics, Inc. (GTHX)

Role
Director
Signature
/s /Sandi James, attorney-in-fact
Stock symbol
GTHX
Transactions as of
Jun 15, 2023
Transactions value $
$0
Form type
4
Date filed
6/16/2023, 04:06 PM
Previous filing
Jun 29, 2022
Next filing
Nov 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTHX Common Stock Award $0 +10K $0.00 10K Jun 15, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +30K $0.00 30K Jun 15, 2023 Common Stock 30K $2.83 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.
F2 Each RSU represents a contingent right to receive one share of Issuer common stock.
F3 The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.